{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cardiovascular diseases", "medicinal plants", "nanoformulation", "nanoparticles", "natural products"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34007178", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "27"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "05", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.2147/IJN.S295508"], "Journal": {"ISSN": "1178-2013", "JournalIssue": {"Volume": "16", "PubDate": {"Year": "2021"}}, "Title": "International journal of nanomedicine", "ISOAbbreviation": "Int J Nanomedicine"}, "ArticleTitle": "Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases.", "Pagination": {"StartPage": "3293", "EndPage": "3315", "MedlinePgn": "3293-3315"}, "Abstract": {"AbstractText": ["Considering the high prevalence of cardiovascular diseases (CVDs), the primary cause of death during the last several decades, it is necessary to develop proper strategies for the prevention and treatment of CVDs. Given the excessive side effects of current therapies, alternative therapeutic approaches like medicinal plants and natural products are preferred. Lower toxicity, chemical diversity, cost-effectiveness, and proven therapeutic potentials make natural products superior compared to other products. Nanoformulation methods improve the solubility, bioavailability, circulation time, surface area-to-volume ratio, systemic adverse side effects, and drug delivery efficiency of these medications. This study intended to review the functionality of the most recent nanoformulated medicinal plants and/or natural products against various cardiovascular conditions such as hypertension, atherosclerosis, thrombosis, and myocardial infarction. Literature review revealed that curcumin, quercetin, and resveratrol were the most applied natural products, respectively. Combination therapy, conjugation, or fabrication of nanoparticles and nanocarriers improved the applications and therapeutic efficacy of herbal- or natural-based nanoformulations. In the context of CVDs prevention and/or treatment, available data suggest that natural-based nanoformulations are considerably efficient, alone or in blend with other herbal/synthetic medicines. However, clinical trials are mandatory to elucidate the safety, cardioprotective effect, and mechanism of actions of nanophytomedicines."], "CopyrightInformation": "\u00a9 2021 Hesari et al."}, "AuthorList": [{"Identifier": ["0000-0001-5884-0844"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Hesari", "ForeName": "Mahvash", "Initials": "M"}, {"Identifier": ["0000-0002-0015-4320"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Mohammadi", "ForeName": "Pantea", "Initials": "P"}, {"Identifier": ["0000-0001-5395-1553"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Khademi", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": ["0000-0002-5919-9750"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Shackebaei", "ForeName": "Dareuosh", "Initials": "D"}, {"Identifier": ["0000-0003-3957-3300"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Gastrointestinal Pharmacology Interest Group, Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": ["0000-0002-4704-0814"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Moasefi", "ForeName": "Narges", "Initials": "N"}, {"Identifier": ["0000-0001-7081-6521"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Technology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Farzaei", "ForeName": "Mohammad Hosein", "Initials": "MH"}, {"Identifier": ["0000-0003-0123-1209"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Abdollahi", "ForeName": "Mohammad", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Int J Nanomedicine", "NlmUniqueID": "101263847", "ISSNLinking": "1176-9114"}, "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Cardiovascular Diseases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["methods"], "DescriptorName": "Nanomedicine"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors have no conflicts of interest to declare for this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "World Health Organization. World Health Statistics 2016: Monitoring Health for the SDGs Sustainable Development Goals. World Health Organization; 2016."}, {"Citation": "Dimmeler S. Cardiovascular disease review series. EMBO Mol Med. 2011;3(12):697. doi:10.1002/emmm.201100182", "ArticleIdList": ["10.1002/emmm.201100182", "PMC3377116", "22113984"]}, {"Citation": "Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:2048004016687211. doi:10.1177/2048004016687211", "ArticleIdList": ["10.1177/2048004016687211", "PMC5331469", "28286646"]}, {"Citation": "Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G; Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:1376. Massachusetts Medical Society. doi:10.1056/NEJM200005043421819", "ArticleIdList": ["10.1056/NEJM200005043421819", "10639539"]}, {"Citation": "Mart\u00edn Gim\u00e9nez VM, Kassuha DE, Manucha W. Nanomedicine applied to cardiovascular diseases: latest developments. Ther Adv Cardiovasc Dis. 2017;11(4):133\u2013142. doi:10.1177/1753944717692293", "ArticleIdList": ["10.1177/1753944717692293", "PMC5933544", "28198204"]}, {"Citation": "Radomska A, Leszczyszyn J, Radomski MW. The nanopharmacology and nanotoxicology of nanomaterials: new opportunities and challenges. Adv Clin Exp Med. 2016;25(1):151\u2013162. doi:10.17219/acem/60879", "ArticleIdList": ["10.17219/acem/60879", "26935510"]}, {"Citation": "Siddiqui A, Iram F, Siddiqui S, Sahu K. Role of natural products in drug discovery process. Int J Drug Dev Res. 2014;6(2):172\u2013204."}, {"Citation": "Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21(5):559.", "ArticleIdList": ["PMC6273146", "27136524"]}, {"Citation": "Clark AM. Natural products as a resource for new drugs. Pharm Res. 1996;13(8):1133\u20131144. doi:10.1023/a:1016091631721", "ArticleIdList": ["10.1023/a:1016091631721", "8865302"]}, {"Citation": "Sorokina M, Steinbeck C. Review on natural products databases: where to find data in 2020. J Cheminform. 2020;12(1):1\u201351. doi:10.1186/s13321-020-00424-9", "ArticleIdList": ["10.1186/s13321-020-00424-9", "PMC7118820", "33431011"]}, {"Citation": "Mushtaq S, Abbasi BH, Uzair B, Abbasi R. Natural products as reservoirs of novel therapeutic agents. EXCLI J. 2018;17:420.", "ArticleIdList": ["PMC5962900", "29805348"]}, {"Citation": "Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S, Kazemi Oskuee R. Novel delivery system for natural products: nano-curcumin formulations. Avicenna J Phytomed. 2016;6(4):383\u2013398.", "ArticleIdList": ["PMC4967834", "27516979"]}, {"Citation": "Taghipour YD, Hajialyani M, Naseri R, et al. Nanoformulations of natural products for management of metabolic syndrome. Int J Nanomedicine. 2019;14:5303\u20135321. doi:10.2147/IJN.S213831", "ArticleIdList": ["10.2147/IJN.S213831", "PMC6642644", "31406461"]}, {"Citation": "Moradi SZ, Momtaz S, Bayrami Z, Farzaei MH, Abdollahi M. Nanoformulations of herbal extracts in treatment of neurodegenerative disorders. Front Bioeng Biotechnol. 2020;8. doi:10.3389/fbioe.2020.00238", "ArticleIdList": ["10.3389/fbioe.2020.00238", "PMC7154137", "32318551"]}, {"Citation": "Rosler A, Vandermeulen GW, Klok HA. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Deliv Rev. 2001;53(1):95\u2013108. doi:10.1016/s0169-409x(01)00222-8", "ArticleIdList": ["10.1016/s0169-409x(01)00222-8", "11733119"]}, {"Citation": "Karthikeyan A, Senthil N, Min T. Nanocurcumin: a promising candidate for therapeutic applications. Front Pharmacol. 2020;11. doi:10.3389/fphar.2020.00487", "ArticleIdList": ["10.3389/fphar.2020.00487", "PMC7206872", "32425772"]}, {"Citation": "Houacine C, Singh KK. 10 Nano resveratrol: a promising future nanonutraceutical. NanoNutraceuticals. 2018."}, {"Citation": "Ahn K. The worldwide trend of using botanical drugs and strategies for developing global drugs. BMB Rep. 2017;50(3):111\u2013116. doi:10.5483/bmbrep.2017.50.3.221", "ArticleIdList": ["10.5483/bmbrep.2017.50.3.221", "PMC5422022", "27998396"]}, {"Citation": "Dong TTX, Cui XM, Song ZH, et al. Chemical assessment of roots of panax notoginseng in China: regional and seasonal variations in its active constituents. J Agric Food Chem. 2003;51(16):4617\u20134623. doi:10.1021/jf034229k", "ArticleIdList": ["10.1021/jf034229k", "14705886"]}, {"Citation": "Rao PR, Viswanath RK. Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats. Exp Clin Cardiol. 2007;12(4):179\u2013187.", "ArticleIdList": ["PMC2359609", "18651002"]}, {"Citation": "Yu B, Fang T-H, Lu G-H, Xu H-Q, Lu J-F. Beneficial effect of cyclovirobuxine D on heart failure rats following myocardial infarction. Fitoterapia. 2011;82(6):868\u2013877. doi:10.1016/j.fitote.2011.04.016", "ArticleIdList": ["10.1016/j.fitote.2011.04.016", "21575690"]}, {"Citation": "Giannouli M, Karagkiozaki V, Pappa F, Moutsios I, Gravalidis C, Logothetidis S. Fabrication of quercetin-loaded PLGA nanoparticles via electrohydrodynamic atomization for cardiovascular disease. Mater Today Proc. 2018;5(8):15998\u201316005. doi:10.1016/j.matpr.2018.05.044", "ArticleIdList": ["10.1016/j.matpr.2018.05.044"]}, {"Citation": "Dinda B, Dinda S, DasSharma S, Banik R, Chakraborty A, Dinda M. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem. 2017;131:68\u201380. doi:10.1016/j.ejmech.2017.03.004", "ArticleIdList": ["10.1016/j.ejmech.2017.03.004", "28288320"]}, {"Citation": "Bremer AA. Resveratrol use in metabolic syndrome. Metab Syndr Relat Disord. 2014;12(10):493\u2013495. doi:10.1089/met.2014.1505", "ArticleIdList": ["10.1089/met.2014.1505", "PMC4251086", "25229675"]}, {"Citation": "Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin. 2010;60(4):222\u2013243. doi:10.3322/caac.20075", "ArticleIdList": ["10.3322/caac.20075", "PMC2919227", "20554717"]}, {"Citation": "Sun G-B, Qin M, Ye J, et al. Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- mice. Toxicol Appl Pharmacol. 2013;271(1):114\u2013126. doi:10.1016/j.taap.2013.04.015", "ArticleIdList": ["10.1016/j.taap.2013.04.015", "23639522"]}, {"Citation": "Hamza A, Amin A, Daoud S. The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell Biol Toxicol. 2008;24(1):63\u201373. doi:10.1007/s10565-007-9016-z", "ArticleIdList": ["10.1007/s10565-007-9016-z", "17520333"]}, {"Citation": "Zanwar AA, Hegde MV, Bodhankar SL. Cardioprotective activity of flax lignan concentrate extracted from seeds of Linum usitatissimum in isoprenalin induced myocardial necrosis in rats. Interdiscip Toxicol. 2011;4(2):90\u201397. doi:10.2478/v10102-011-0016-8", "ArticleIdList": ["10.2478/v10102-011-0016-8", "PMC3131680", "21753905"]}, {"Citation": "Li X, Fang Q, Tian X, et al. Curcumin attenuates the development of thoracic aortic aneurysm by inhibiting VEGF expression and inflammation. Mol Med Rep. 2017;16(4):4455\u20134462. doi:10.3892/mmr.2017.7169", "ArticleIdList": ["10.3892/mmr.2017.7169", "PMC5647005", "28791384"]}, {"Citation": "Campbell MS, Fleenor BS. The emerging role of curcumin for improving vascular dysfunction: a review. Crit Rev Food Sci Nutr. 2018;58(16):2790\u20132799. doi:10.1080/10408398.2017.1341865", "ArticleIdList": ["10.1080/10408398.2017.1341865", "28662351"]}, {"Citation": "Allijn IE, Czarny BMS, Wang X, et al. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. J Control Release. 2017;247:127\u2013133. doi:10.1016/j.jconrel.2016.12.042", "ArticleIdList": ["10.1016/j.jconrel.2016.12.042", "28065862"]}, {"Citation": "Cavia-Saiz M, Busto M, Pilar-Izquierdo M, Ortega Santamar\u00eda N, Perez-Mateos M, Mu\u00f1iz P. Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a Comparative Study. J Sci Food Agric. 2010;90(7):1238\u20131244. doi:10.1002/jsfa.3959", "ArticleIdList": ["10.1002/jsfa.3959", "20394007"]}, {"Citation": "Hernandez-Abreu O, Torres-Piedra M, Garcia-Jimenez S, et al. Dose-dependent antihypertensive determination and toxicological studies of tilianin isolated from Agastache mexicana. J Ethnopharmacol. 2013;146(1):187\u2013191. doi:10.1016/j.jep.2012.12.029", "ArticleIdList": ["10.1016/j.jep.2012.12.029", "23276782"]}, {"Citation": "Guo X, Cao W, Yao J, et al. Cardioprotective effects of tilianin in rat myocardial ischemia-reperfusion injury. Mol Med Rep. 2014;11. doi:10.3892/mmr.2014.2954", "ArticleIdList": ["10.3892/mmr.2014.2954", "25405380"]}, {"Citation": "Stoll A, Seebeck E. Chemical investigations on alliin, the specific principle of garlic. Adv Enzymol Relat Subj Biochem. 1951;11:377\u2013400. doi:10.1002/9780470122563.ch8", "ArticleIdList": ["10.1002/9780470122563.ch8", "24540596"]}, {"Citation": "Hashemzaei M, Delarami Far A, Yari A, et al. Anticancer and apoptosis\u2011inducing effects of quercetin in vitro and in vivo. Oncol Rep. 2017;38(2):819\u2013828. doi:10.3892/or.2017.5766", "ArticleIdList": ["10.3892/or.2017.5766", "PMC5561933", "28677813"]}, {"Citation": "Pereira M, Siba IP, Chioca LR, et al. Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(7):1636\u20131644. doi:10.1016/j.pnpbp.2011.06.002", "ArticleIdList": ["10.1016/j.pnpbp.2011.06.002", "21689712"]}, {"Citation": "Patra JK, Das FL. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16. doi:10.1186/s12951-018-0392-8", "ArticleIdList": ["10.1186/s12951-018-0392-8", "PMC6145203", "30231877"]}, {"Citation": "Lombardo D, Kiselev MA, Caccamo MT. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater. 2019;2019:1\u201326. doi:10.1155/2019/3702518", "ArticleIdList": ["10.1155/2019/3702518"]}, {"Citation": "Gao W, Zhang L. Coating nanoparticles with cell membranes for targeted drug delivery. J Drug Target. 2015;23(7\u20138):619\u2013626. doi:10.3109/1061186X.2015.1052074", "ArticleIdList": ["10.3109/1061186X.2015.1052074", "26453159"]}, {"Citation": "Kayal S, Ramanujan RV. Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery. Mater Sci Eng C. 2010;30(3):484\u2013490. doi:10.1016/j.msec.2010.01.006", "ArticleIdList": ["10.1016/j.msec.2010.01.006"]}, {"Citation": "Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R, Hubalek J. Magnetic nanoparticles and targeted drug delivering. Pharmacol Res. 2010;62(2):144\u2013149. doi:10.1016/j.phrs.2010.01.014", "ArticleIdList": ["10.1016/j.phrs.2010.01.014", "20149874"]}, {"Citation": "Lundy DJ, Chen K-H, Toh EK-W, Hsieh PC-H. Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury. Sci Rep. 2016;6:25613. doi:10.1038/srep25613", "ArticleIdList": ["10.1038/srep25613", "PMC4861966", "27161857"]}, {"Citation": "Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, Diwan PV. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm. 2007;335(1\u20132):167\u2013175. doi:10.1016/j.ijpharm.2006.11.004", "ArticleIdList": ["10.1016/j.ijpharm.2006.11.004", "17161566"]}, {"Citation": "Broz P, Ben-Haim N, Grzelakowski M, Marsch S, Meier W, Hunziker P. Inhibition of macrophage phagocytotic activity by a receptor-targeted polymer vesicle-based drug delivery formulation of pravastatin. J Cardiovasc Pharmacol. 2008;51(3):246\u2013252. doi:10.1097/FJC.0b013e3181624aed", "ArticleIdList": ["10.1097/FJC.0b013e3181624aed", "18356688"]}, {"Citation": "La Francesca S. Nanotechnology and stem cell therapy for cardiovascular diseases: potential applications. Methodist Debakey Cardiovasc J. 2012;8(1):28\u201335. doi:10.14797/mdcj-8-1-28", "ArticleIdList": ["10.14797/mdcj-8-1-28", "PMC3405790", "22891108"]}, {"Citation": "Binsalamah ZM, Paul A, Khan AA, Prakash S, Shum-Tim D. Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model. Int J Nanomedicine. 2011;6:2667\u20132678. doi:10.2147/IJN.S25175", "ArticleIdList": ["10.2147/IJN.S25175", "PMC3218580", "22114497"]}, {"Citation": "Myerson J, He L, Lanza G, Tollefsen D, Wickline S. Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis. J Thromb Haemost. 2011;9(7):1292\u20131300. doi:10.1111/j.1538-7836.2011.04339.x", "ArticleIdList": ["10.1111/j.1538-7836.2011.04339.x", "PMC3686484", "21605330"]}, {"Citation": "Waltenberger B, Mocan A, \u0160mejkal K, Heiss EH, Atanasov AG. Natural products to counteract the epidemic of cardiovascular and metabolic disorders. Molecules. 2016;21(6):807.", "ArticleIdList": ["PMC4928700", "27338339"]}, {"Citation": "Sobhani Z, Reza Nami S, Ahmad Emami S, Sahebkar A, Javadi B. Medicinal plants targeting cardiovascular diseases in view of Avicenna. Curr Pharm Des. 2017;23(17):2428\u20132443.", "ArticleIdList": ["28215156"]}, {"Citation": "Petrovska BB. Historical review of medicinal plants\u2019 usage. Pharmacogn Rev. 2012;6(11):1.", "ArticleIdList": ["PMC3358962", "22654398"]}, {"Citation": "Lin MC, Nahin R, Gershwin ME, Longhurst JC, Wu KK. State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop. Circulation. 2001;103(16):2038\u20132041.", "ArticleIdList": ["11319191"]}, {"Citation": "J\u00e9r\u00f4me C, Lecomte P. Recent advances in the synthesis of aliphatic polyesters by ring-opening polymerization. Adv Drug Deliv Rev. 2008;60(9):1056\u20131076.", "ArticleIdList": ["18403043"]}, {"Citation": "Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005;4(3):206\u2013220.", "ArticleIdList": ["15729362"]}, {"Citation": "Du Y, Liu P, Yuan Z, et al. Simultaneous qualitative and quantitative analysis of 28 components in Isodon rubescens by HPLC\u2010ESI\u2010MS/MS. J Sep Sci. 2010;33(4\u20105):545\u2013557.", "ArticleIdList": ["20135707"]}, {"Citation": "Kariyazono H, Nakamura K, Shinkawa T, Yamaguchi T, Sakata R, Yamada K. Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol. Thromb Res. 2001;101(6):445\u2013453.", "ArticleIdList": ["11323002"]}, {"Citation": "Sanz MJ, Cortijo J, Morcillo EJ. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression. Pharmacol Ther. 2005;106(3):269\u2013297.", "ArticleIdList": ["15922015"]}, {"Citation": "Wang Y, Tang J, Zhu H, et al. Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis. Int J Nanomedicine. 2015;10:6905.", "ArticleIdList": ["PMC4639563", "26604756"]}, {"Citation": "Atale N, Jaiswal A, Chhabra A, et al. Phytochemical and antioxidant screening of Syzygium cumini seed extracts: a comparative study. J Pharm Res. 2011;4(12):4530\u20134532."}, {"Citation": "Neha A, Vibha R. GC-MS analysis of bioactive components in the ethanolic and methanolic extract of Syzygium cumini. Int J Pharma Bio Sci. 2013;4(4)."}, {"Citation": "Atale N, Chakraborty M, Mohanty S, et al. Cardioprotective role of syzygium cumini against glucose-induced oxidative stress in H9C2 cardiac myocytes. Cardiovasc Toxicol. 2013;13. doi:10.1007/s12012-013-9207-1", "ArticleIdList": ["10.1007/s12012-013-9207-1", "23512199"]}, {"Citation": "Atale N, Gupta K, Rani V. Protective effect of Syzygium cumini against pesticide-induced cardiotoxicity. Environ Sci Pollut Res. 2014;21(13):7956\u20137972.", "ArticleIdList": ["24659402"]}, {"Citation": "Atale N, Saxena S, Nirmala JG, Narendhirakannan RT, Mohanty S, Rani V. Synthesis and characterization of Sygyzium cumini nanoparticles for its protective potential in high glucose-induced cardiac stress: a green approach. Appl Biochem Biotechnol. 2017;181(3):1140\u20131154.", "ArticleIdList": ["27734287"]}, {"Citation": "Ferretti G, Bacchetti T, Belleggia A, Neri D. Cherry antioxidants: from farm to table. Molecules. 2010;15(10):6993\u20137005.", "ArticleIdList": ["PMC6259571", "20944519"]}, {"Citation": "Scalbert A, Manach C, Morand C, R\u00e9m\u00e9sy C, Jim\u00e9nez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr. 2005;45(4):287\u2013306.", "ArticleIdList": ["16047496"]}, {"Citation": "Beconcini D, Fabiano A, Zambito Y, et al. Chitosan-based nanoparticles containing cherry extract from Prunus avium L. to improve the resistance of endothelial cells to oxidative stress. Nutrients. 2018;10(11). doi:10.3390/nu10111598", "ArticleIdList": ["10.3390/nu10111598", "PMC6266270", "30388730"]}, {"Citation": "Beconcini D, Fabiano A, Di Stefano R, et al. Cherry extract from Prunus avium L. to improve the resistance of endothelial cells to oxidative stress: mucoadhesive chitosan vs. poly (lactic-co-glycolic acid) nanoparticles. Int J Mol Sci. 2019;20(7):1759.", "ArticleIdList": ["PMC6480209", "30974730"]}, {"Citation": "Beconcini D, Felice F, Zambito Y, et al. Anti-inflammatory effect of cherry extract loaded in polymeric nanoparticles: relevance of particle internalization in endothelial cells. Pharmaceutics. 2019;11(10):500.", "ArticleIdList": ["PMC6835553", "31569594"]}, {"Citation": "Najafi M, Ghasemian E, Fathiazad F, Garjani A. Effects of total extract of dracocephalum moldavica on ischemia/reperfusion induced arrhythmias and infarct size in the isolated rat heart. Iran J Basic Med Sci. 2009;11(4):229\u2013235. doi:10.22038/ijbms.2009.5186", "ArticleIdList": ["10.22038/ijbms.2009.5186"]}, {"Citation": "Yang LN, Xing JG, He CH, Yang PM. Chemical constituents of Dracocephalum moldavica L. and their pharmacological activities. World Clin Drugs. 2013;34(4):226\u2013231."}, {"Citation": "Jiang J, Yuan X, Wang T, et al. Antioxidative and cardioprotective effects of total flavonoids extracted from Dracocephalum moldavica L. against acute ischemia/reperfusion-induced myocardial injury in isolated rat heart. Cardiovasc Toxicol. 2014;14(1):74\u201382.", "ArticleIdList": ["24395711"]}, {"Citation": "Tan M, He C, Jiang W, et al. Development of solid lipid nanoparticles containing total flavonoid extract from Dracocephalum moldavica L. and their therapeutic effect against myocardial ischemia\u2013reperfusion injury in rats. Int J Nanomedicine. 2017;12:3253.", "ArticleIdList": ["PMC5402922", "28458544"]}, {"Citation": "Ghayur MN, Gilani AH, Rasheed H, et al. Cardiovascular and airway relaxant activities of peony root extract. Can J Physiol Pharmacol. 2008;86(11):793\u2013803. doi:10.1139/Y08-084", "ArticleIdList": ["10.1139/Y08-084", "19011675"]}, {"Citation": "Ibrar M, Khan MA, Nisar M, Khan M. Evaluation of Paeonia emodi for its cardioprotective potentials: an investigative study towards possible mechanism. J Ethnopharmacol. 2019;231:57\u201365.", "ArticleIdList": ["30391709"]}, {"Citation": "Ibrar M, Khan MA, Imran M. Evaluation of Paeonia emodi and its gold nanoparticles for cardioprotective and antihyperlipidemic potentials. J Photochem Photobiol B Biol. 2018;189:5\u201313.", "ArticleIdList": ["30268952"]}, {"Citation": "Li -Y-Y, Feng J, Zhang X-L, Cui -Y-Y. Pine bark extracts: nutraceutical, pharmacological, and toxicological evaluation. J Pharmacol Exp Ther. 2015;353(1):9\u201316.", "ArticleIdList": ["25597308"]}, {"Citation": "Park I-J, Cha S-Y, Kang M, et al. Effect of proanthocyanidin-rich extract from Pinus radiata bark on immune response of specific-pathogen-free white leghorn chickens. Poult Sci. 2011;90(5):977\u2013982.", "ArticleIdList": ["21489942"]}, {"Citation": "Sudjarwo S, Anwar C, Eraiko K, Koerniasari WG. Cardioprotective activity of Chitosan-Pinus merkusii extract nanoparticles against lead acetate induced cardiac cell damage in rat. Rasayan J Chem. 2019;12:184\u2013191. doi:10.31788/RJC.2019.1215049", "ArticleIdList": ["10.31788/RJC.2019.1215049"]}, {"Citation": "Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2008;46(2):409\u2013420. doi:10.1016/J.FCT.2007.09.085", "ArticleIdList": ["10.1016/J.FCT.2007.09.085", "17950516"]}, {"Citation": "Verma SK, Singh M, Jain P, Bordia A. Protective Effect of Ginger, Zingiber Officinale Rosc on Experimental Atherosclerosis in Rabbits. 2004.", "ArticleIdList": ["15339040"]}, {"Citation": "Young H-Y, Liao J-C, Chang Y-S, Luo Y-L, Lu M-C, Peng W-H. Synergistic effect of ginger and nifedipine on human platelet aggregation: a study in hypertensive patients and normal volunteers. Am J Chin Med. 2006;34(04):545\u2013551.", "ArticleIdList": ["16883626"]}, {"Citation": "Ghayur MN, Gilani AH, Afridi MB, Houghton PJ. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascul Pharmacol. 2005;43(4):234\u2013241.", "ArticleIdList": ["16157513"]}, {"Citation": "Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr. 2006;96(4):660\u2013666.", "ArticleIdList": ["17010224"]}, {"Citation": "Borcan F, Chirita-Emandi A, Andreescu NI, et al. Synthesis and preliminary characterization of polyurethane nanoparticles with ginger extract as a possible cardiovascular protector. Int J Nanomedicine. 2019;14:3691.", "ArticleIdList": ["PMC6535673", "31190819"]}, {"Citation": "Atanasov AG, Waltenberger B, Pferschy-Wenzig E-M, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv. 2015;33(8):1582\u20131614.", "ArticleIdList": ["PMC4748402", "26281720"]}, {"Citation": "Hosseinzadeh L, Behravan J, Mosaffa F, Bahrami G, Bahrami AR, Karimi G. Effect of curcumin on doxorubicin-induced cytotoxicity in H9c2 cardiomyoblast cells. Iran J Basic Med Sci. 2011;14(1):49\u201356."}, {"Citation": "Kocaadam B, \u015eanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017;57(13):2889\u20132895.", "ArticleIdList": ["26528921"]}, {"Citation": "He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. 2015;20(5):9183\u20139213.", "ArticleIdList": ["PMC6272784", "26007179"]}, {"Citation": "Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807\u2013818.", "ArticleIdList": ["17999464"]}, {"Citation": "Rachmawati H, Soraya IS, Kurniati NF, Rahma A. In vitro study on antihypertensive and antihypercholesterolemic effects of a curcumin nanoemulsion. Sci Pharm. 2016;84(1):131\u2013140.", "ArticleIdList": ["PMC4839556", "27110504"]}, {"Citation": "Tong F, Chai R, Jiang H, Dong B. In vitro/vivo drug release and antidiabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles. Int J Nanomedicine. 2018;13:1945.", "ArticleIdList": ["PMC5892954", "29662310"]}, {"Citation": "Boarescu P-M, Boarescu I, Boc\u0219an IC, et al. Antioxidant and anti-inflammatory effects of curcumin nanoparticles on drug-induced acute myocardial infarction in diabetic rats. Antioxidants. 2019;8(10):504.", "ArticleIdList": ["PMC6826579", "31652638"]}, {"Citation": "Hardy N, Viola HM, Johnstone VPA, et al. Nanoparticle-mediated dual delivery of an antioxidant and a peptide against the L-type Ca2+ channel enables simultaneous reduction of cardiac ischemia-reperfusion injury. ACS Nano. 2015;9(1):279\u2013289.", "ArticleIdList": ["25493575"]}, {"Citation": "Ray A, Rana S, Banerjee D, et al. Improved bioavailability of targeted curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment. Toxicol Appl Pharmacol. 2016;290:54\u201365.", "ArticleIdList": ["26612707"]}, {"Citation": "Rice KM, Manne NDPK, Kolli MB, et al. Curcumin nanoparticles attenuate cardiac remodeling due to pulmonary arterial hypertension. Artif Cells Nanomed Biotechnol. 2016;44(8):1909\u20131916.", "ArticleIdList": ["26631548"]}, {"Citation": "Boarescu P-M, Boarescu I, Boc\u0219an IC, et al. Curcumin nanoparticles protect against isoproterenol induced myocardial infarction by alleviating myocardial tissue oxidative stress, electrocardiogram, and biological changes. Molecules. 2019;24(15):2802.", "ArticleIdList": ["PMC6696485", "31374848"]}, {"Citation": "Ranjan AP, Mukerjee A, Helson L, Vishwanatha JK. Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translation. J Nanobiotechnology. 2013;11(1):40.", "ArticleIdList": ["PMC3878673", "24330336"]}, {"Citation": "Boarescu P-M, Chiril\u0103 I, Bulboac\u0103 AE, et al. Effects of curcumin nanoparticles in isoproterenol-induced myocardial infarction. Oxid Med Cell Longev. 2019;2019.", "ArticleIdList": ["PMC6530192", "31205590"]}, {"Citation": "Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN. ARBITER: arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 2002;106(16):2055\u20132060.", "ArticleIdList": ["12379573"]}, {"Citation": "Aydin U, Ugurlucan M, Gungor F, et al. Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model. Angiology. 2009;60(3):370\u2013377. Sage Publications Sage CA: Los Angeles, CA. doi:10.1177/0003319708321102", "ArticleIdList": ["10.1177/0003319708321102", "18796450"]}, {"Citation": "Olszanecki R, Jawie\u0144 J, Gajda M, et al. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol. 2005;56(4):627\u2013635.", "ArticleIdList": ["16391419"]}, {"Citation": "Li X, Xiao H, Lin C, et al. Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis. Int J Nanomedicine. 2019;14:649. doi:10.2147/IJN.S189819", "ArticleIdList": ["10.2147/IJN.S189819", "PMC6339643", "30697048"]}, {"Citation": "Abdel-Mageid AD, Abou-Salem MES, Salaam NMHA, El-Garhy HAS. The potential effect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats. Phytomedicine. 2018;43:126\u2013134. doi:10.1016/j.phymed.2018.04.039", "ArticleIdList": ["10.1016/j.phymed.2018.04.039", "29747745"]}, {"Citation": "Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2012;1(3):295\u2013305. doi:10.1002/cam4.35", "ArticleIdList": ["10.1002/cam4.35", "PMC3544465", "23342279"]}, {"Citation": "Nabofa WEE, Alashe OO, Oyeyemi OT, et al. Cardioprotective effects of curcumin-nisin based poly lactic acid nanoparticle on myocardial infarction in guinea pigs. Sci Rep. 2018;8(1). doi:10.1038/s41598-018-35145-5", "ArticleIdList": ["10.1038/s41598-018-35145-5", "PMC6226538", "30413767"]}, {"Citation": "Sunagawa Y, Wada H, Suzuki H, et al. A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in rats. Biol PharmBull. 2012;35(2):139\u2013144.", "ArticleIdList": ["22293342"]}, {"Citation": "Yadav YC, Pattnaik S, Swain K. Curcumin loaded mesoporous silica nanoparticles: assessment of bioavailability and cardioprotective effect. Drug Dev Ind Pharm. 2019;45(12):1889\u20131895. doi:10.1080/03639045.2019.1672717", "ArticleIdList": ["10.1080/03639045.2019.1672717", "31549866"]}, {"Citation": "Li J, Zhou Y, Zhang W, Bao C, Xie Z. Relief of oxidative stress and cardiomyocyte apoptosis by using curcumin nanoparticles. Colloids Surf B Biointerfaces. 2017;153:174\u2013182. doi:10.1016/j.colsurfb.2017.02.023", "ArticleIdList": ["10.1016/j.colsurfb.2017.02.023", "28237821"]}, {"Citation": "Simion V, Stan D, Constantinescu CA, et al. Conjugation of curcumin\u2010loaded lipid nanoemulsions with cell-penetrating peptides increases their cellular uptake and enhances the anti-inflammatory effects in endothelial cells. J Pharm Pharmacol. 2016;68(2):195\u2013207. doi:10.1111/jphp.12513", "ArticleIdList": ["10.1111/jphp.12513", "26748549"]}, {"Citation": "Zhang J, Wang Y, Bao C, et al. Curcumin\u2011loaded PEG\u2011PDLLA nanoparticles for attenuating palmitate\u2011induced oxidative stress and cardiomyocyte apoptosis through AMPK pathway. Int J Mol Med. 2019;44(2):672\u2013682. doi:10.3892/ijmm.2019.4228", "ArticleIdList": ["10.3892/ijmm.2019.4228", "PMC6605976", "31173176"]}, {"Citation": "Namdari M, Eatemadi A. Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines. Artif Cells Nanomed Biotechnol. 2017;45(4):731\u2013739. doi:10.1080/21691401.2016.1261033", "ArticleIdList": ["10.1080/21691401.2016.1261033", "27924631"]}, {"Citation": "Du Preez R, Pahl J, Arora M, Ravi kumar MNV, Brown L, Panchal SK. Low-dose curcumin nanoparticles normalise blood pressure in male Wistar rats with diet-induced metabolic syndrome. Nutrients. 2019;11(7):1542. doi:10.3390/nu11071542", "ArticleIdList": ["10.3390/nu11071542", "PMC6682951", "31288419"]}, {"Citation": "Liu Y, Liu Q, Liu Y, Ju F, Ma Q, He Q. In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: a novel strategy. J Photochem Photobiol B Biol. 2019;199:111619. doi:10.1016/j.jphotobiol.2019.111619", "ArticleIdList": ["10.1016/j.jphotobiol.2019.111619", "31622787"]}, {"Citation": "Cheng L, Sun X, Hu C, et al. In vivo early intervention and the therapeutic effects of 20 (S)-ginsenoside Rg3 on hypertrophic scar formation. PLoS One. 2014;9(12):12. doi:10.1371/journal.pone.0113640", "ArticleIdList": ["10.1371/journal.pone.0113640", "PMC4264739", "25502572"]}, {"Citation": "Li L, Ni J, Li M, et al. Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy. Drug Deliv. 2017;24(1):1617\u20131630. doi:10.1080/10717544.2017.1391893", "ArticleIdList": ["10.1080/10717544.2017.1391893", "PMC8241051", "29063791"]}, {"Citation": "Yang L, Wang B, Gan H, et al. Enhanced oral bioavailability and anti\u2010tumour effect of paclitaxel by 20 (s)\u2010ginsenoside Rg3 in vivo. Biopharm Drug Dispos. 2012;33(8):425\u2013436. doi:10.1002/bdd.1806", "ArticleIdList": ["10.1002/bdd.1806", "22898996"]}, {"Citation": "Chen Z-H, Li J, Liu J, et al. Saponins isolated from the root of Panax notoginseng showed significant antidiabetic effects in KK-Ay mice. Am J Chin Med. 2008;36(05):939\u2013951. doi:10.1142/S0192415X08006363", "ArticleIdList": ["10.1142/S0192415X08006363", "19051359"]}, {"Citation": "Lee J, Lee E, Kim D, Lee J, Yoo J, Koh B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J Ethnopharmacol. 2009;122(1):143\u2013148. doi:10.1016/j.jep.2008.12.012", "ArticleIdList": ["10.1016/j.jep.2008.12.012", "19146939"]}, {"Citation": "Zhang J, Han X, Li X, et al. Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in rats. Int J Nanomedicine. 2012;7:4299. doi:10.2147/IJN.S32385", "ArticleIdList": ["10.2147/IJN.S32385", "PMC3419509", "22915851"]}, {"Citation": "Deng Y, Yang M, Xu F, et al. Combined salvianolic acid B and ginsenoside Rg1 exerts cardioprotection against ischemia/reperfusion injury in rats. PLoS One. 2015;10(8):e0135435. doi:10.1371/journal.pone.0135435", "ArticleIdList": ["10.1371/journal.pone.0135435", "PMC4539231", "26280455"]}, {"Citation": "Qiu J, Cai G, Liu X, Ma D. \u03b1v\u03b23 integrin receptor specific peptide modified, salvianolic acid B and panax notoginsenoside loaded nanomedicine for the combination therapy of acute myocardial ischemia. Biomed Pharmacother. 2017;96:1418\u20131426. doi:10.1016/j.biopha.2017.10.086", "ArticleIdList": ["10.1016/j.biopha.2017.10.086", "29079344"]}, {"Citation": "Yoo JS, Lee J, Jung JH, et al. SPECT/CT imaging of high-risk atherosclerotic plaques using integrin-binding RGD dimer peptides. Sci Rep. 2015;5(1):11752. doi:10.1038/srep11752", "ArticleIdList": ["10.1038/srep11752", "PMC4485237", "26123253"]}, {"Citation": "Ikram M. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med. 1975;28(08):353\u2013358. doi:10.1055/s-0028-1097869", "ArticleIdList": ["10.1055/s-0028-1097869", "1208684"]}, {"Citation": "P\u00e9rez-Rubio KG, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Robles-Cervantes JA, Espinel-Berm\u00fadez MC. Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord. 2013;11(5):366\u2013369. doi:10.1089/met.2012.0183", "ArticleIdList": ["10.1089/met.2012.0183", "23808999"]}, {"Citation": "Gautam R, Jachak SM. Recent developments in anti-inflammatory natural products. Med Res Rev. 2009;29(5):767\u2013820. doi:10.1002/med.20156", "ArticleIdList": ["10.1002/med.20156", "19378317"]}, {"Citation": "Huang Z, Han Z, Ye B, et al. Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes. Eur J Pharmacol. 2015;762:1\u201310. doi:10.1016/j.ejphar.2015.05.028", "ArticleIdList": ["10.1016/j.ejphar.2015.05.028", "26004523"]}, {"Citation": "Renugadevi J, Shagirtha K. In vivo and in vitro antioxidative efficacy of naringenin on cadmium-induced toxicity in rats. Res Rev a J Toxicol. 2013;3(3):9\u201316."}, {"Citation": "Manach C, Scalbert A, Morand C, R\u00e9m\u00e9sy C, Jim\u00e9nez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79(5):727\u2013747.", "ArticleIdList": ["15113710"]}, {"Citation": "Maity S, Mukhopadhyay P, Kundu PP, Chakraborti AS. Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals\u2014An in vitro and in vivo approach. Carbohydr Polym. 2017;170:124\u2013132. doi:10.1016/j.carbpol.2017.04.066", "ArticleIdList": ["10.1016/j.carbpol.2017.04.066", "28521977"]}, {"Citation": "Shulman M, Cohen M, Soto-Gutierrez A, et al. Enhancement of naringenin bioavailability by complexation with hydroxypropoyl-\u03b2-cyclodextrin. PLoS One. 2011;6(4):e18033. doi:10.1371/journal.pone.0018033", "ArticleIdList": ["10.1371/journal.pone.0018033", "PMC3071816", "21494673"]}, {"Citation": "Fuior EV, Deleanu M, Constantinescu CA, et al. Functional role of VCAM-1 targeted flavonoid-loaded lipid nanoemulsions in reducing endothelium inflammation. Pharmaceutics. 2019;11(8):391. doi:10.3390/pharmaceutics11080391", "ArticleIdList": ["10.3390/pharmaceutics11080391", "PMC6722676", "31382634"]}, {"Citation": "Yuan Y, Cao W, Hong Y, et al. Tilianin pretreatment prevents myocardial ischemia-reperfusion injury via preservation of mitochondrial function in rat heart. Phytomedicine. 2017;34:106\u2013114. doi:10.1016/j.phymed.2017.08.007", "ArticleIdList": ["10.1016/j.phymed.2017.08.007", "28899492"]}, {"Citation": "Cheng XM, Ma TY, Su L, et al. Separation and authentication of tilianin and quality standards of semen of Dracocephalum moldavia. Zhongguo Zhong Yao Za Zhi. 2015;40(10):1845\u20131849.", "ArticleIdList": ["26390635"]}, {"Citation": "Wang Y, Wang Y, Wang X, Hu P. Tilianin loaded ROS-scavenging nano-micelles protect H9c2 cardiomyocyte against hypoxia/reoxygenation-induced injury. J Cardiovasc Pharmacol. 2018;72(1):32\u201339. doi:10.1097/FJC.0000000000000587", "ArticleIdList": ["10.1097/FJC.0000000000000587", "29688912"]}, {"Citation": "Tang M, Hu P, Zheng Q, et al. Polymeric micelles with dual thermal and reactive oxygen species (ROS)-responsiveness for inflammatory cancer cell delivery. J Nanobiotechnology. 2017;15(1):39. doi:10.1186/s12951-017-0275-4", "ArticleIdList": ["10.1186/s12951-017-0275-4", "PMC5434630", "28511687"]}, {"Citation": "Han R-M, Tian Y-X, Becker EM, Andersen ML, Zhang J-P, Skibsted LH. Puerarin and conjugate bases as radical scavengers and antioxidants: molecular mechanism and synergism with \u03b2-carotene. J Agric Food Chem. 2007;55(6):2384\u20132391. doi:10.1021/jf062796c", "ArticleIdList": ["10.1021/jf062796c", "17300199"]}, {"Citation": "Wong KH, Li GQ, Li KM, Razmovski-Naumovski V, Chan K. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol. 2011;134(3):584\u2013607. doi:10.1016/j.jep.2011.02.001", "ArticleIdList": ["10.1016/j.jep.2011.02.001", "21315814"]}, {"Citation": "Luo C-F, Yuan M, Chen M-S, et al. Determination of puerarin in rat plasma by rapid resolution liquid chromatography tandem mass spectrometry in positive ionization mode. J Chromatogr B. 2011;879(19):1497\u20131501. doi:10.1016/j.jchromb.2011.03.035", "ArticleIdList": ["10.1016/j.jchromb.2011.03.035", "21511546"]}, {"Citation": "Li W, Wu J, Zhang J, et al. Puerarin-loaded PEG-PE micelles with enhanced antiapoptotic effect and better pharmacokinetic profile. Drug Deliv. 2018;25(1):827\u2013837. doi:10.1080/10717544.2018.1455763", "ArticleIdList": ["10.1080/10717544.2018.1455763", "PMC6058490", "29587545"]}, {"Citation": "Li W, Wu J, Xiang D, et al. Micelles loaded with puerarin and modified with triphenylphosphonium cation possess mitochondrial targeting and demonstrate enhanced protective effect against isoprenaline-induced H9c2 cells apoptosis. Int J Nanomedicine. 2019;14:8345. doi:10.2147/IJN.S219670", "ArticleIdList": ["10.2147/IJN.S219670", "PMC6814317", "31695371"]}, {"Citation": "Shan D, Li J, Cai P, et al. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of \u03b1 v \u03b2 3 integrin-overexpressing breast cancer cells. Drug Deliv Transl Res. 2015;5(1):15\u201326. doi:10.1007/s13346-014-0210-2", "ArticleIdList": ["10.1007/s13346-014-0210-2", "25787336"]}, {"Citation": "Yu J, Gu Y, Du KT, Mihardja S, Sievers RE, Lee RJ. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials. 2009;30(5):751\u2013756. doi:10.1016/j.biomaterials.2008.09.059", "ArticleIdList": ["10.1016/j.biomaterials.2008.09.059", "19010528"]}, {"Citation": "Dong Z, Guo J, Xing X, Zhang X, Du Y, Lu Q. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: formulation, characterization and protective effects on acute myocardial ischemia model. Biomed Pharmacother. 2017;89:297\u2013304. doi:10.1016/j.biopha.2017.02.029", "ArticleIdList": ["10.1016/j.biopha.2017.02.029", "28236703"]}, {"Citation": "Liu X, Ding Y, Zhao B, et al. In vitro and in vivo evaluation of puerarin-loaded PEGylated mesoporous silica nanoparticles. Drug Dev Ind Pharm. 2016;42(12):2031\u20132037. doi:10.1080/03639045.2016.1190742", "ArticleIdList": ["10.1080/03639045.2016.1190742", "27282345"]}, {"Citation": "Larson A, Witman MAH, Guo Y, et al. Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide. Nutr Res. 2012;32(8):557\u2013564. doi:10.1016/j.nutres.2012.06.018", "ArticleIdList": ["10.1016/j.nutres.2012.06.018", "22935338"]}, {"Citation": "Cai X, Fang Z, Dou J, Yu A, Zhai G. Bioavailability of quercetin: problems and promises. Curr Med Chem. 2013;20(20):2572\u20132582. doi:10.2174/09298673113209990120", "ArticleIdList": ["10.2174/09298673113209990120", "23514412"]}, {"Citation": "Soloviev A, Stefanov A, Parshikov A, et al. Arrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposomes. Cardiovasc Toxicol. 2002;2(2):129\u2013139. doi:10.1385/CT:2:2:129", "ArticleIdList": ["10.1385/CT:2:2:129", "12271156"]}, {"Citation": "Cote B, Carlson LJ, Rao DA, Alani AWG. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo. J Control Release. 2015;213:128\u2013133. doi:10.1016/j.jconrel.2015.06.040", "ArticleIdList": ["10.1016/j.jconrel.2015.06.040", "26160305"]}, {"Citation": "Lozano O, L\u00e1zaro-Alfaro A, Silva-Platas C, et al. Nanoencapsulated quercetin improves cardioprotection during hypoxia-reoxygenation injury through preservation of mitochondrial function. Oxid Med Cell Longev. 2019;2019:1\u201314. doi:10.1155/2019/7683051", "ArticleIdList": ["10.1155/2019/7683051", "PMC6612997", "31341535"]}, {"Citation": "Wang L, Feng M, Li Y, et al. Fabrication of superparamagnetic nano-silica@ quercetin-encapsulated PLGA nanocomposite: potential application for cardiovascular diseases. J Photochem Photobiol B Biol. 2019;196:111508. doi:10.1016/j.jphotobiol.2019.05.005", "ArticleIdList": ["10.1016/j.jphotobiol.2019.05.005", "31152936"]}, {"Citation": "Waisundara VY, Hsu A, Tan BK-H, Huang D. Baicalin improves antioxidant status of streptozotocin-induced diabetic Wistar rats. J Agric Food Chem. 2009;57(10):4096\u20134102. doi:10.1021/jf8028539", "ArticleIdList": ["10.1021/jf8028539", "19364111"]}, {"Citation": "Kong F, Luan Y, Zhang Z, Cheng G, Qi T, Sun C. Baicalin protects the myocardium from reperfusion\u2011induced damage in isolated rat hearts via the antioxidant and paracrine effect. Exp Ther Med. 2014;7(1):254\u2013259. doi:10.3892/etm.2013.1369", "ArticleIdList": ["10.3892/etm.2013.1369", "PMC3861453", "24348801"]}, {"Citation": "Zhang S, Wang J, Pan J. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv. 2016;23(9):3696\u20133703. doi:10.1080/10717544.2016.1223218", "ArticleIdList": ["10.1080/10717544.2016.1223218", "27749105"]}, {"Citation": "Pangeni R, Sahni JK, Ali J, Sharma S, Baboota S. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin Drug Deliv. 2014;11(8):1285\u20131298. doi:10.1517/17425247.2014.919253", "ArticleIdList": ["10.1517/17425247.2014.919253", "24830814"]}, {"Citation": "Cottart C, Nivet\u2010Antoine V, Laguillier\u2010Morizot C, Beaudeux J. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res. 2010;54(1):7\u201316. doi:10.1002/mnfr.200900437", "ArticleIdList": ["10.1002/mnfr.200900437", "20013887"]}, {"Citation": "Shahraki A, Bahadorikhalili S, Hashemzaei M, et al. Resveratrol nanocapsule as an efficient tool for blood pressure regulation: a study on metabolic syndrome induced mice. Biosci Biotechnol Res Commun. 2017;10(4):623\u2013630. doi:10.21786/bbrc/10.4/4", "ArticleIdList": ["10.21786/bbrc/10.4/4"]}, {"Citation": "Carlson LJ, Cote B, Alani AWG, Rao DA. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity. J Pharm Sci. 2014;103(8):2315\u20132322. doi:10.1002/jps.24042", "ArticleIdList": ["10.1002/jps.24042", "24914015"]}, {"Citation": "Zhang L, Zhu K, Zeng H, et al. Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity. Int J Nanomedicine. 2019;14:6061. doi:10.2147/IJN.S211130", "ArticleIdList": ["10.2147/IJN.S211130", "PMC6681569", "31534336"]}, {"Citation": "Fei X, Chen X, Liang G, et al. Preparation, characterization, and biodistribution of breviscapine proliposomes in heart. J Drug Target. 2009;17(5):408\u2013414. doi:10.1080/10611860902913380", "ArticleIdList": ["10.1080/10611860902913380", "19555267"]}, {"Citation": "Lu J, Cheng C, Zhao X, et al. PEG-scutellarin prodrugs: synthesis, water solubility and protective effect on cerebral ischemia/reperfusion injury. Eur J Med Chem. 2010;45(5):1731\u20131738. doi:10.1016/j.ejmech.2010.01.006", "ArticleIdList": ["10.1016/j.ejmech.2010.01.006", "20117861"]}, {"Citation": "Xiong F, Wang H, Geng K, Gu N, Zhu J. Optimized preparation, characterization and biodistribution in heart of breviscapine lipid emulsion. Chem Pharm Bull. 2010;58(11):1455\u20131460. doi:10.1248/cpb.58.1455", "ArticleIdList": ["10.1248/cpb.58.1455", "21048336"]}, {"Citation": "Lee Y-J, Lee YM, Lee C-K, Jung JK, Han SB, Hong JT. Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther. 2011;130(2):157\u2013176. doi:10.1016/j.pharmthera.2011.01.010", "ArticleIdList": ["10.1016/j.pharmthera.2011.01.010", "21277893"]}, {"Citation": "Yang S, Hsieh M, Tsai T, Hsu S. Effector mechanism of magnolol\u2010induced apoptosis in human lung squamous carcinoma CH27 cells. Br J Pharmacol. 2003;138(1):193\u2013201. doi:10.1038/sj.bjp.0705024", "ArticleIdList": ["10.1038/sj.bjp.0705024", "PMC1573650", "12522090"]}, {"Citation": "Amorati R, Zotova J, Baschieri A, Valgimigli L. Antioxidant activity of magnolol and honokiol: kinetic and mechanistic investigations of their reaction with peroxyl radicals. J Org Chem. 2015;80(21):10651\u201310659. doi:10.1021/acs.joc.5b01772", "ArticleIdList": ["10.1021/acs.joc.5b01772", "26447942"]}, {"Citation": "Yang B, Xu Y, Yu S, Huang Y, Lu L, Liang X. Anti-angiogenic and anti-inflammatory effect of Magnolol in the oxygen-induced retinopathy model. Inflamm Res. 2016;65(1):81\u201393. doi:10.1007/s00011-015-0894-x", "ArticleIdList": ["10.1007/s00011-015-0894-x", "26547789"]}, {"Citation": "Liang X, Xing W, He J, et al. Magnolol administration in normotensive young spontaneously hypertensive rats postpones the development of hypertension: role of increased PPAR gamma, reduced TRB3 and resultant alleviative vascular insulin resistance. PLoS One. 2015;10(3).", "ArticleIdList": ["PMC4367990", "25793876"]}, {"Citation": "Liang C-J, Lee C-W, Sung H-C, et al. Magnolol reduced TNF-\u03b1-induced vascular cell adhesion molecule-1 expression in endothelial cells via JNK/p38 and NF-\u03baB signaling pathways. Am J Chin Med. 2014;42(03):619\u2013637. doi:10.1142/S0192415X14500402", "ArticleIdList": ["10.1142/S0192415X14500402", "24871655"]}, {"Citation": "Chen CY, Wu C. Magnolol encapsulated by liposome in inhibiting smooth muscle cell proliferation. J Chinese Chem Soc. 2008;55(3):517\u2013521. doi:10.1002/jccs.200800076", "ArticleIdList": ["10.1002/jccs.200800076"]}, {"Citation": "Lee C-W, Hu -SC-S, Yen F-L, et al. Magnolol nanoparticles exhibit improved water solubility and suppress TNF-\u03b1-induced VCAM-1 expression in endothelial cells. J Biomed Nanotechnol. 2017;13(3):255\u2013268. doi:10.1166/jbn.2017.2342", "ArticleIdList": ["10.1166/jbn.2017.2342", "29381027"]}, {"Citation": "Ananingsih VK, Sharma A, Zhou W. Green tea catechins during food processing and storage: a review on stability and detection. Food Res Int. 2013;50(2):469\u2013479. doi:10.1016/j.foodres.2011.03.004", "ArticleIdList": ["10.1016/j.foodres.2011.03.004"]}, {"Citation": "Hong MH, Kim MH, Chang HJ, et al. (\u2212)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-\u03baB signaling. Life Sci. 2007;80(21):1957\u20131965. doi:10.1016/j.lfs.2007.02.024", "ArticleIdList": ["10.1016/j.lfs.2007.02.024", "17379255"]}, {"Citation": "Hong J, Lu H, Meng X, Ryu J-H, Hara Y, Yang CS. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (\u2212)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 2002;62(24):7241\u20137246.", "ArticleIdList": ["12499265"]}, {"Citation": "Zhang J, Nie S, Martinez-Zaguilan R, Sennoune SR, Wang S. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles. J Nutr Biochem. 2016;30:14\u201323. doi:10.1016/j.jnutbio.2015.11.001", "ArticleIdList": ["10.1016/j.jnutbio.2015.11.001", "PMC4808521", "27012617"]}, {"Citation": "Zhang J, Nie S, Wang S. Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages. J Agric Food Chem. 2013;61(38):9200\u20139209. doi:10.1021/jf4023004", "ArticleIdList": ["10.1021/jf4023004", "PMC3840090", "24020822"]}, {"Citation": "Feng J, Li S, Chen H. Tanshinone IIA inhibits myocardial remodeling induced by pressure overload via suppressing oxidative stress and inflammation: possible role of silent information regulator 1. Eur J Pharmacol. 2016;791:632\u2013639. doi:10.1016/j.ejphar.2016.09.041", "ArticleIdList": ["10.1016/j.ejphar.2016.09.041", "27693799"]}, {"Citation": "Gao S, Liu Z, Li H, Little PJ, Liu P, Xu S. Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis. 2012;220(1):3\u201310. doi:10.1016/j.atherosclerosis.2011.06.041", "ArticleIdList": ["10.1016/j.atherosclerosis.2011.06.041", "21774934"]}, {"Citation": "Li J, Liu P, Liu J-P, Zhang W-L, Yang J-K, Fan Y-Q. Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2012;80(2):426\u2013432. doi:10.1016/j.ejpb.2011.11.003", "ArticleIdList": ["10.1016/j.ejpb.2011.11.003", "22119664"]}, {"Citation": "Zhang W, He H, Liu J, et al. Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins. Biomaterials. 2013;34(1):306\u2013319. doi:10.1016/j.biomaterials.2012.09.058", "ArticleIdList": ["10.1016/j.biomaterials.2012.09.058", "23069716"]}, {"Citation": "Zhang S, Li J, Hu S, Wu F, Zhang X. Triphenylphosphonium and D-\u03b1-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction. Int J Nanomedicine. 2018;13:4045. doi:10.2147/IJN.S165590", "ArticleIdList": ["10.2147/IJN.S165590", "PMC6045899", "30022826"]}, {"Citation": "Mao S, Wang L, Chen P, Lan Y, Guo R, Zhang M. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-\u03baB pathway. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S707\u2013S716. doi:10.1080/21691401.2018.1508028", "ArticleIdList": ["10.1080/21691401.2018.1508028", "30284484"]}, {"Citation": "Badore N, Das P, Pillai S, Thakur A. Role of Ginkgo biloba extract, against isoproterenol induced cardiac toxicity in rats. Indian J Pharm Educ Res. 2017;51(4s):s691\u2013s699. doi:10.5530/ijper.51.4s.100", "ArticleIdList": ["10.5530/ijper.51.4s.100"]}, {"Citation": "Oyama Y, Fuchs PA, Katayama N, Noda K. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons. Brain Res. 1994;635(1\u20132):125\u2013129. doi:10.1016/0006-8993(94)91431-1", "ArticleIdList": ["10.1016/0006-8993(94)91431-1", "8173947"]}, {"Citation": "Roy S, Chaudhuri T. A quantitative assessment of bioactive phytochemicals of Nerium indicum: an ethnopharmacological herb. Int J Res Pharm Sci. 2012;3:579\u2013587."}, {"Citation": "Ahmed Q, Gupta N, Kumar A, Nimesh S. Antibacterial efficacy of silver nanoparticles synthesized employing Terminalia arjuna bark extract. Artif Cells Nanomed Biotechnol. 2017;45(6):1\u20139. doi:10.1080/21691401.2016.1215328", "ArticleIdList": ["10.1080/21691401.2016.1215328", "27684206"]}, {"Citation": "Aqil F, Ahmad I, Mehmood Z. Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. Turkish J Biol. 2006;30:177\u2013183."}, {"Citation": "Aa A, Pb K, Pattiyappan S, Ra U, Peo R. Phytochemical screening of Sesbania grandiflora (Linn). Int J Biosci Nanosci. 2014;1:2014."}, {"Citation": "Hamid K, Ng I, Tallapragada VJ, et al. An investigation of the differential effects of ursane triterpenoids from Centella asiatica, and their semisynthetic analogues, on GABAA receptors. Chem Biol Drug Des. 2016;88(3):386\u2013397. doi:10.1111/cbdd.12766", "ArticleIdList": ["10.1111/cbdd.12766", "27062315"]}, {"Citation": "Mridula K, Parthibhan S, Kumar T, Rao M. In vitro organogenesis from Tinospora cordifolia (Willd.) Miers \u2014 a highly valuable medicinal plant. S Afr J Bot. 2017;113:84\u201390. doi:10.1016/j.sajb.2017.08.003", "ArticleIdList": ["10.1016/j.sajb.2017.08.003"]}, {"Citation": "Upadhyay AK, Kumar K, Kumar A, Mishra HS. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) - validation of the Ayurvedic pharmacology through experimental and clinical studies. Int J Ayurveda Res. 2010;1(2):112\u2013121. doi:10.4103/0974-7788.64405", "ArticleIdList": ["10.4103/0974-7788.64405", "PMC2924974", "20814526"]}, {"Citation": "Nitika G, Meena A, Jaspreet N. Evaluation of physicochemical and preliminary phytochemical studies on the root of bombax ceiba linn. Int Res J Pharm. 2011;924\u2013926."}, {"Citation": "Patel S, Verma N, Rathore B, Nayak G, Singhai A, Singh P. Cardioprotective effect of Bombax ceiba flowers against acute adriamycin-induced myocardial infarction in rats. Rev Bras Farmacogn. 2011;21(4):704\u2013709. doi:10.1590/S0102-695X2011005000090", "ArticleIdList": ["10.1590/S0102-695X2011005000090"]}, {"Citation": "Helal AM, Nakamura N, El-Askary H, Hattori M. Sesquiterpene lactone glucosides from Sonchus asper. Phytochemistry. 2000;53(4):473\u2013477. doi:10.1016/S0031-9422(99)00516-6", "ArticleIdList": ["10.1016/S0031-9422(99)00516-6", "10731026"]}, {"Citation": "Khan M. Prevention of KBrO3-induced cardiotoxicity by Sonchus asper in rat. J Med Plant Res. 2011."}, {"Citation": "Juhasz B, Kertesz A, Balla J, et al. Cardioprotective effects of sour cherry seed extract (SCSE) on the hypercholesterolemic rabbit heart. Curr Pharm Des. 2013;19(39):6896\u20136905. doi:10.2174/138161281939131127120517", "ArticleIdList": ["10.2174/138161281939131127120517", "23590152"]}, {"Citation": "Yaqoob D. Paeonia Emodi: An Ethnopharmacological and Phytochemical Review. 2017."}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "3"}, {"Year": "2021", "Month": "4", "Day": "16"}, {"Year": "2021", "Month": "5", "Day": "19", "Hour": "6", "Minute": "44"}, {"Year": "2021", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["34007178", "PMC8123960", "10.2147/IJN.S295508", "295508"]}}], "PubmedBookArticle": []}